Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
January 1, 2014World Journal of CardiologyOpen Access

Genetic evaluation and testing in pediatric cardiomyopathy is essential for establishing a diagnosis, guiding clinical management, and facilitating family-based risk assessment.

View Full Paper
Ask AI
Bookmark
Share

Population

Pediatric patients with cardiomyopathy

Design

Review

Key result

Genetic evaluation and testing in pediatric cardiomyopathy is essential for establishing a diagnosis, guiding clinical management, and facilitating family-based risk assessment.

Authors

MTMuhammad Tariq

Discussion

Loading...

Member takes

Overview

Comprehensive genetic evaluation in pediatric cardiomyopathy is crucial for clinical diagnosis and may help identify novel therapeutic targets.

Structured PICO

P
Population
Pediatric patients with cardiomyopathy (including hypertrophic, dilated, restrictive, left ventricular noncompaction, and arrhythmogenic right ventricular cardiomyopathy)
I
Intervention
Genetic evaluation and testing

Comprehensive genetic evaluation in pediatric cardiomyopathy is crucial for clinical diagnosis and may help identify novel therapeutic targets.

Cite This Study

Muhammad Tariq (2014) conducted a review in Pediatric cardiomyopathy. Genetic evaluation and testing was evaluated. Genetic evaluation and testing in pediatric cardiomyopathy is essential for establishing a diagnosis, guiding clinical management, and facilitating family-based risk assessment.

synapsesocial.com/papers/6a6d3aaaf44fa9f079db963dhttps://doi.org/10.4330/wjc.v6.i11.1156
View Full Paper
Ask AI
Bookmark
Share